Package 16571-828-09

{"route": ["ORAL"], "spl_id": "0ea90fd4-0da6-4ad2-ab83-6cfbe0ae515e", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000175562", "N0000000181"], "unii": ["0J48LPH2TH", "9G64RSX1XD"], "rxcui": ["197436", "197437", "197438", "197439"], "spl_set_id": ["0ea90fd4-0da6-4ad2-ab83-6cfbe0ae515e"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin Converting Enzyme Inhibitor [EPC]"], "pharm_class_moa": ["Angiotensin-converting Enzyme Inhibitors [MoA]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (16571-828-09)", "package_ndc": "16571-828-09", "marketing_start_date": "20230214"}], "brand_name": "CAPTOPRIL AND HYDROCHLOROTHIAZIDE", "product_id": "16571-828_0ea90fd4-0da6-4ad2-ab83-6cfbe0ae515e", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "16571-828", "generic_name": "CAPTOPRIL AND HYDROCHLOROTHIAZIDE", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CAPTOPRIL AND HYDROCHLOROTHIAZIDE", "active_ingredients": [{"name": "CAPTOPRIL", "strength": "25 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}], "application_number": "ANDA074896", "marketing_category": "ANDA", "marketing_start_date": "20230214", "listing_expiration_date": "20261231"}